ImpediMed Announces Half Year Results Heralding Positive Year Ahead
February 1, 2008
In announcing its Half Year Results, ImpediMed (ASX: IPD) heralded a positive year ahead with the planned launch of a new medical device to breast surgeons in the US involved i the clinical assessment of lymphedema in breast cancer patients.
View full story here